Cargando…
The role of p16 as a biomarker in nonoropharyngeal head and neck cancer
Autores principales: | Vitzthum, Lucas K., Mell, Loren K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6161792/ https://www.ncbi.nlm.nih.gov/pubmed/30279955 http://dx.doi.org/10.18632/oncotarget.26053 |
Ejemplares similares
-
Treatment Considerations for Patients with Locoregionally Advanced Head and Neck Cancer with a Contraindication to Cisplatin
por: Kim, Sangwoo S., et al.
Publicado: (2023) -
Comparison of Hematologic Toxicity and Bone Marrow Compensatory Response in Head and Neck vs. Cervical Cancer Patients Undergoing Chemoradiotherapy
por: Vitzthum, Lucas K., et al.
Publicado: (2020) -
Defining the Role of Immunotherapy in the Curative Treatment of Locoregionally Advanced Head and Neck Cancer: Promises, Challenges, and Opportunities
por: Saddawi-Konefka, Robert, et al.
Publicado: (2021) -
Head and Neck Soft Tissue Sarcomas Treated with Radiation Therapy
por: Vitzthum, Lucas K., et al.
Publicado: (2016) -
Incidence of Long-Term Esophageal Dilation With Various Treatment Approaches in the Older Head and Neck Cancer Population
por: Green, Garrett, et al.
Publicado: (2018)